1 / 1

LNCaP

Figure S1. LNCaP. LY294002. -. +. +. Hours. -. 12. 24. p-AKT. AKT. p53. p21. ß-actin. Figure legend S1: LNCaP cells were treated with the PI3K inhibitor LY294002 ( 20 m m ) for the indicated time points.

bryant
Télécharger la présentation

LNCaP

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure S1 LNCaP LY294002 - + + Hours - 12 24 p-AKT AKT p53 p21 ß-actin Figure legend S1: LNCaP cells were treated with the PI3K inhibitor LY294002 (20 mm) for the indicated time points. Immunoblots were probed for antibodies targeted to p-AKT, AKT, P53, P21 and actin. Treatment with LY294002 causes inhibition of the phosphorylation of AKT (Ser 473). There is no change in the levels of P53 protein.

More Related